CRIS Current Research Information System

RIZZELLO, FERNANDO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 12.142
AS - Asia 10.477
EU - Europa 7.859
AF - Africa 790
SA - Sud America 700
OC - Oceania 20
Continente sconosciuto - Info sul continente non disponibili 9
Totale 31.997
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.916
SG - Singapore 2.789
VN - Vietnam 2.745
CN - Cina 2.594
IT - Italia 1.811
GB - Regno Unito 1.633
DE - Germania 941
SE - Svezia 783
HK - Hong Kong 745
FR - Francia 560
BR - Brasile 514
IN - India 471
RU - Federazione Russa 410
UA - Ucraina 349
IE - Irlanda 300
NL - Olanda 227
KR - Corea 214
FI - Finlandia 203
ZA - Sudafrica 196
CI - Costa d'Avorio 183
JP - Giappone 181
SC - Seychelles 158
TG - Togo 154
BD - Bangladesh 142
CH - Svizzera 116
BG - Bulgaria 109
EE - Estonia 108
JO - Giordania 108
AR - Argentina 91
CA - Canada 90
PH - Filippine 82
BE - Belgio 67
ES - Italia 51
IQ - Iraq 51
ID - Indonesia 49
MX - Messico 49
PL - Polonia 49
TH - Thailandia 41
TR - Turchia 41
HN - Honduras 38
TW - Taiwan 38
AT - Austria 36
SA - Arabia Saudita 30
GR - Grecia 27
PK - Pakistan 27
UZ - Uzbekistan 27
NG - Nigeria 24
EC - Ecuador 20
CL - Cile 19
IR - Iran 19
AU - Australia 17
BZ - Belize 17
CO - Colombia 15
EG - Egitto 15
PY - Paraguay 15
LT - Lituania 14
CZ - Repubblica Ceca 13
RO - Romania 13
ET - Etiopia 12
VE - Venezuela 12
MY - Malesia 11
LB - Libano 10
MA - Marocco 10
TN - Tunisia 9
HR - Croazia 8
KE - Kenya 8
IL - Israele 7
JM - Giamaica 7
KZ - Kazakistan 7
NP - Nepal 7
PT - Portogallo 7
AE - Emirati Arabi Uniti 6
AZ - Azerbaigian 6
DZ - Algeria 6
BO - Bolivia 5
EU - Europa 5
PE - Perù 5
PS - Palestinian Territory 5
AL - Albania 4
CR - Costa Rica 4
DO - Repubblica Dominicana 4
MD - Moldavia 4
SK - Slovacchia (Repubblica Slovacca) 4
SY - Repubblica araba siriana 4
TT - Trinidad e Tobago 4
UY - Uruguay 4
A2 - ???statistics.table.value.countryCode.A2??? 3
MN - Mongolia 3
RS - Serbia 3
BB - Barbados 2
BF - Burkina Faso 2
BW - Botswana 2
DK - Danimarca 2
GD - Grenada 2
GE - Georgia 2
HU - Ungheria 2
LA - Repubblica Popolare Democratica del Laos 2
LV - Lettonia 2
MU - Mauritius 2
NO - Norvegia 2
Totale 31.961
Salva come PNG Salva come JPEG
Città #
Singapore 1.901
Ashburn 1.389
Southend 1.351
Fairfield 1.054
Chandler 835
Hong Kong 699
San Jose 639
Ho Chi Minh City 602
Woodbridge 530
Santa Clara 527
Houston 498
Hanoi 487
Hefei 481
Wilmington 459
Seattle 434
Princeton 386
Beijing 375
Cambridge 346
Bologna 336
Dong Ket 326
Ann Arbor 325
Dublin 299
Boardman 245
Lauterbourg 216
Abidjan 183
Jacksonville 179
New York 178
Seoul 178
Nanjing 171
Helsinki 169
Los Angeles 169
Lomé 154
Tokyo 153
Westminster 148
Milan 134
Council Bluffs 131
Padova 123
Berlin 122
Buffalo 109
Sofia 108
Amman 107
San Diego 101
Dallas 98
Frankfurt am Main 98
Bern 92
Da Nang 85
Haiphong 84
Rome 82
São Paulo 81
Turin 76
Shenyang 75
Redondo Beach 71
Jinan 70
Saint Petersburg 66
Guangzhou 65
Johannesburg 64
Phoenix 61
Changsha 58
Munich 57
Bengaluru 52
Hebei 50
Shanghai 49
Brussels 48
Orem 46
Redwood City 44
Mülheim 43
Medford 41
Redmond 39
London 38
Nanchang 38
Chicago 36
Des Moines 36
Bremen 35
Florence 34
Nuremberg 34
Tianjin 34
Yubileyny 34
Dearborn 33
Henderson 33
San Francisco 33
Atlanta 30
Falkenstein 28
Montreal 28
Zhengzhou 28
Hangzhou 27
Saint Louis 27
Centro 26
Falls Church 26
Hải Dương 26
Jiaxing 26
Can Tho 25
Biên Hòa 24
Boston 24
Mahé 24
Norwalk 24
Modena 23
Thái Nguyên 23
Toronto 23
Washington 23
Amsterdam 22
Totale 19.977
Salva come PNG Salva come JPEG
Nome #
Refractory Complex Crohn's Perianal Fistulas: A Role for Autologous Microfragmented Adipose Tissue Injection 678
Ulcerative Colitis 372
Dietary geraniol ameliorates intestinal dysbiosis and relieves symptoms in irritable bowel syndrome patients: a pilot study. 320
Human cord blood-derived platelet lysate enhances the therapeutic activity of adipose-derived mesenchymal stromal cells isolated from Crohn's disease patients in a mouse model of colitis 310
COVID-19 in IBD: The experience of a single tertiary IBD center 306
A Heavy Feeling in the Stomach: Neural Correlates of Anxiety in Crohn's Disease 258
Adult attachment and early parental experiences in patients with Crohn’s Disease 258
Absence of change in the gray matter volume of patients with ulcerative colitis in remission: a voxel based morphometry study 246
Can supplementation of phytoestrogens/insoluble fibers help the management of duodenal polyps in familial adenomatous polyposis? 244
Management of pouch dysfunction or pouchitis with an ileoanal pouch. 243
Geraniol Treatment for Irritable Bowel Syndrome: A Double-Blind Randomized Clinical Trial 240
Dietary geraniol by oral or enema administration strongly reduces dysbiosis and systemic inflammation in dextran sulfate sodium-treated mice 237
A-Transducin, a Signaling Molecule of the Chemoreceptive Cascade, Is Expressed in Endocrine and Non-Endocrine Cells of the Pig Gastrointestinal Mucosa 236
Real-time elastography for the detection of fibrotic and inflammatory tissue in patients with stricturing Crohn's disease 232
Four cases of carcinoid tumour in Crohn's disease: coincidence or correlation? 227
Performance of Capsule Endoscopy and Cross-Sectional Techniques in Detecting Small Bowel Lesions in Patients with Crohn’s Disease 224
Cell proliferation of esophageal squamous epithelium in erosive and non-erosive reflux disease 223
Medical treatment and management of severe ulcerative colitis 221
Distinct proteomic profiles characterise non-erosive from erosive reflux disease. 219
Infliximab in the treatment of Crohn's disease 217
Adalimumab in active ulcerative colitis: a "real-life" observational study. 215
Cyclooxygenase-2 Silencing for the Treatment of Colitis: A Combined In Vivo Strategy Based on RNA Interference and Engineered Escherichia Coli 215
Attachment and quality of life in patients with inflammatory bowel disease 215
Clinical management of severe active ulcerative colitis in the TNF-α inhibitors era 214
Prevalence and effectiveness of psychiatric treatments for patients with IBD: A systematic literature review 212
Short-term treatment with Infliximab in chronic refractory pouchitis and ileitis. 211
High-dose probiotics for the treatment of active pouchitis 210
Probiotics, Prebiotics and Antibiotics in the Treatment of Inflammatory Bowel Disease 210
Cutaneous Manifestations in Inflammatory Bowel Diseases: Eight Cases of Psoriasis Induced by Anti-Tumor-Necrosis-Factor Antibody Therapy 200
MODULATION OF HUMAN DENDRITIC CELL PHENOTYPE AND FUNCTION BY PROBIOTIC BACTERIA 199
Adalimumab Clearance, rather than Trough Level, May Have Greatest Relevance to Crohn's Disease Therapeutic Outcomes Assessed Clinically and Endoscopically 198
Drug delivery by polymeric micelles: an in vitro and in vivo study to deliver lipophilic substances to colonocytes and selectively target inflamed colon 198
Effectiveness of swapping to ustekinumab after vedolizumab failure in patients with multi-refractory Crohn's disease 197
Infliximab in the treatment of Crohn's disease: predictors of response in an Italian multicentric open study 197
Percutaneous Drainage vs. Surgery as Definitive Treatment for Anastomotic Leak after Intestinal Resection in Patients with Crohn's Disease 196
Implications of the westernized diet in the onset and progression of IBD 196
Implications of antioxidant enzymes in human gastric neoplasms 195
Platelet lysate enhances the therapeutic activity of Adipose Derived Mesenchymal stromal cells isolated from Crohn disease patients in a novel Mouse model of Colitis 195
Bacterial and fungal microbiota in relation to probiotic therapy (VSL#3) in pouchitis 194
Clinical course of microscopic colitis in a single-center cohort study 193
Potential role of the cannabinoid receptor CB in the pathogenesis of erosive and non-erosive gastro-oesophageal reflux disease 192
Brain functional changes in patients with ulcerative colitis: a functional magnetic resonance imaging study on emotional processing 192
Adalimumab in the Treatment of Perianal Crohn's Disease: A Single Center in 64 Patients 191
Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis. 190
Functional magnetic resonance imaging study reveals differences in the habituation to psychological stress in patients with Crohn's disease versus healthy controls 190
Antibiotics and probiotics in treatment of inflammatory bowel disease 188
Controlled study using wireless capsule endoscopy for the evaluation of the small intestine in chronic refractory pouchitis 187
Management and treatment of distal ulcerative colitis 187
Ninety-six-hour wireless oesophageal pH monitoring following proton pump inhibitor administration in NERD patients. 187
Nutritional Biomarkers for the Prediction of Response to Anti-TNF-α Therapy in Crohn's Disease: New Tools for New Approaches 187
Oral budesonide in the treatment of chronic refractory pouchitis. 186
3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn's Disease 2016: Part 1: Diagnosis and Medical Management 186
Systematic review with meta-analysis: Diagnostic performance of faecal calprotectin in distinguishing inflammatory bowel disease from irritable bowel syndrome in adults 182
Review article: aminosalicylates for distal colitis 182
P151 Characteristics of presentation and risk factors for early recurrence after strictureplasty for Crohn’s disease of the small bowel in the biological era 182
Management of inflammatory bowel disease: does rifaximin offer any promises 181
Role of conventional therapies in the era of biological treatment in Crohn's disease. 181
Differential Brain Structural and Functional Patterns in Crohn's Disease Patients are Associated with Different Disease Stages 180
Loss of miR-101 expression promotes Wnt/β-catenin signalling pathway activation and malignancy in colon cancer cells 180
Parental Bonding and Inflammatory Bowel Disease 180
Probiotics in IBD: A critical review 180
Dietary Habits and Nutrient Deficiencies in a Cohort of European Crohn's Disease Adult Patients 180
ADALIMUMAB IN THE TREATMENT OF PERIANAL CROHN'S DISEASE: LONG TERM RESULTS IN A SINGLE TERTIARY CENTRE 178
Role of Biologics in refractory pouchitis 178
ADALIMUMAB IN THE TREATMENT OF PERIANAL CROHN'S DISEASE: A SINGLE CENTER EXPERIENCE IN 64 PATIENTS 177
Interaction of probiotic Lactobacillus and Bifidobacterium strains with human intestinal epithelial cells: adhesion properties, competition against enteropathogens and modulation of IL-8 production 176
Percutaneous abdomino-pelvic abscess drainage in complicated Crohn’s disease 176
MANAGEMENT OF POUCHITIS 175
The role of Budesonide-MMX in active ulcerative colitis. 174
Medical Treatment of Ulcerative Colitis: does traditional therapy still have a role? 173
COMBINATION OF SURGICAL THERAPY AND LOCAL INJECTIONS OF ADALIMUMAB IN TREATEMENT OF COMPLEX PERIANAL CROHN'S DISEASE 172
Selective cyclooxygenase-2 (COX-2) silencing mediated by engineered Escherichia coli and RNA Interference induces anti-tumour effects in human colon cancer cells 172
Oral Budesonide and low serum albumin levels at surgery are associated with a higher risk of postoperative intra-abdominal septic complications after primary ileocaecal resection for Crohn's disease: A retrospective analysis of 853 consecutive patients 171
Which therapies are advisable in pouchitis? 170
Antimicrobials in the management of inflammatory bowel disease 170
Is CMV DNAemia an early marker of CMV colitis in patients with active ulcerative colitis? 169
Pre-pouch ileitis 169
P325 Risk factors for lymph node involvement in patients undergoing ileal pouch-anal anastomosis for ulcerative colitis complicated by colorectal cancer in the biological years 169
Comparison of intestinal ultrasound, conventional enteroclysis, CT and MRI enteroclysis, surgical findings for determining complications in patients with Crohn's Disease 167
Local Injection of Infliximab for the Treatment of Perianal Crohn's Disease. 165
Sympathetic hyperactivity in patients with ulcerative colitis. 164
Randomized controlled trials in pouchitis 164
Transabdominal salvage surgery after pouch failure in a tertiary center: a case-matched study 164
Sporadic small bowel tumors detected by capsule endoscopy in patients with occult gastrointestinal bleeding 164
Eviendep® reduces number and size of duodenal polyps in familial adenomatous polyposis patients with ileal pouch-anal anastomosis 163
A current overview of corticosteroid use in active ulcerative colitis 163
Safety and Efficacy of Vedolizumab in Kidney Transplant Recipients With Crohn’s Disease 163
Oral beclomethasone dipropionate in chronic refractory pouchitis 162
New insights into the brain involvement in patients with Crohn's disease: a voxel-based morphometry study 162
Combined carriership of TLR9-1237C and CD14-260T alleles enhances the risk of developing chronic relapsing pouchitis 162
Problematic proctitis and distal colitis 162
Budesonide MMX: efficacy and safety profile in the treatment of ulcerative colitis 162
Topical treatment of distal active ulcerative colitis with beclometasone dipropionato or mesalamine: a single-blind randomized controlled trial 160
OC.01.8 USE OF INFLIXIMAB AND ADALIMUMAB IN REFRACTORY POUCHITIS 160
The Bidirectional Link between Nutritional Factors and Inflammatory Bowel Diseases: Dietary Deficits, Habits, and Recommended Interventions-A Narrative Review 158
Rescue therapy: ciclosporin or infliximab? 157
Local injection of adalimumab for perianal Crohn's disease: better than infliximab? 157
DOP62 Morbidity after primary ileocecal resection for Crohn’s disease in the years of biologics: Lesson learned over 631 patients exclusively treated in a tertiary centre 157
Probiotics, Prebiotics, and Antibiotics in IBD 155
Obscure gastrointestinal bleeding: single centre experience of capsule endoscopy. 154
Totale 19.956
Salva come PNG Salva come JPEG
Categoria #
all - tutte 92.700
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 92.700
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021742 0 0 0 0 0 0 0 0 0 0 0 742
2021/20223.313 352 93 217 160 295 168 83 194 202 236 817 496
2022/20233.789 396 510 184 460 247 316 102 209 736 104 269 256
2023/20241.219 80 199 109 92 95 290 73 76 35 65 46 59
2024/20254.588 248 686 388 291 720 225 284 160 108 339 215 924
2025/202611.401 1.021 1.124 966 830 1.239 701 1.141 372 2.228 966 499 314
Totale 32.772